Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
Name | Price | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anti-TAL2 antibody (1-80 aa) (STJ190224) | Login | Anti-TAL2 antibody (1-80 aa) (STJ190224) | ||||||||||||||||
|
||||||||||||||||||
Anti-AGK antibody (330-410 aa) (STJ190226) | Login | Anti-AGK antibody (330-410 aa) (STJ190226) | ||||||||||||||||
|
||||||||||||||||||
Anti-CT83 antibody (30-110 aa) (STJ190227) | Login | Anti-CT83 antibody (30-110 aa) (STJ190227) | ||||||||||||||||
|
||||||||||||||||||
Anti-NKX2-3 antibody (STJ190895) | Login | Anti-NKX2-3 antibody (STJ190895) | ||||||||||||||||
|
||||||||||||||||||
Anti-TGIF2 antibody (STJ190900) | Login | Anti-TGIF2 antibody (STJ190900) | ||||||||||||||||
|
||||||||||||||||||
Anti-TGIF2LX antibody (STJ190901) | Login | Anti-TGIF2LX antibody (STJ190901) | ||||||||||||||||
|
||||||||||||||||||
Anti-TGIF2LY antibody (STJ190902) | Login | Anti-TGIF2LY antibody (STJ190902) | ||||||||||||||||
|
||||||||||||||||||
Anti-VPREB1 antibody (STJ190906) | Login | Anti-VPREB1 antibody (STJ190906) | ||||||||||||||||
|
||||||||||||||||||
Anti-KLHL42 antibody (STJ190914) | Login | Anti-KLHL42 antibody (STJ190914) | ||||||||||||||||
|
||||||||||||||||||
Anti-KIR2DL2 antibody (STJ190916) | Login | Anti-KIR2DL2 antibody (STJ190916) | ||||||||||||||||
|
||||||||||||||||||
Anti-KIR2DL5A antibody (STJ190917) | Login | Anti-KIR2DL5A antibody (STJ190917) | ||||||||||||||||
|
||||||||||||||||||
Anti-KIR2DS5 antibody (STJ190918) | Login | Anti-KIR2DS5 antibody (STJ190918) | ||||||||||||||||
|
||||||||||||||||||
Anti-PPFIA1 antibody (980-1060 aa) (STJ190927) | Login | Anti-PPFIA1 antibody (980-1060 aa) (STJ190927) | ||||||||||||||||
|
||||||||||||||||||
Anti-LRP1B antibody (200-280 aa) (STJ190935) | Login | Anti-LRP1B antibody (200-280 aa) (STJ190935) | ||||||||||||||||
|
||||||||||||||||||
Anti-LRP4 antibody (290-370 aa) (STJ190937) | Login | Anti-LRP4 antibody (290-370 aa) (STJ190937) | ||||||||||||||||
|
||||||||||||||||||
Anti-MAML2 antibody (10-90 aa) (STJ190941) | Login | Anti-MAML2 antibody (10-90 aa) (STJ190941) | ||||||||||||||||
|
||||||||||||||||||
Anti-MED10 antibody (40-120 aa) (STJ190943) | Login | Anti-MED10 antibody (40-120 aa) (STJ190943) | ||||||||||||||||
|
||||||||||||||||||
Anti-MED28 antibody (20-100 aa) (STJ190947) | Login | Anti-MED28 antibody (20-100 aa) (STJ190947) | ||||||||||||||||
|
||||||||||||||||||
Anti-MED30 antibody (70-150 aa) (STJ190949) | Login | Anti-MED30 antibody (70-150 aa) (STJ190949) | ||||||||||||||||
|
||||||||||||||||||
Anti-MED4 antibody (200-280 aa) (STJ190951) | Login | Anti-MED4 antibody (200-280 aa) (STJ190951) | ||||||||||||||||
|
||||||||||||||||||
Anti-MRAP antibody (20-100 aa) (STJ190953) | Login | Anti-MRAP antibody (20-100 aa) (STJ190953) | ||||||||||||||||
|
||||||||||||||||||
Anti-MIA3 antibody (1110-1190 aa) (STJ190954) | Login | Anti-MIA3 antibody (1110-1190 aa) (STJ190954) | ||||||||||||||||
|
||||||||||||||||||
Anti-MELTF antibody (210-290 aa) (STJ190955) | Login | Anti-MELTF antibody (210-290 aa) (STJ190955) | ||||||||||||||||
|
||||||||||||||||||
Anti-CD46 antibody (10-90 aa) (STJ190956) | Login | Anti-CD46 antibody (10-90 aa) (STJ190956) | ||||||||||||||||
|
||||||||||||||||||
Anti-PGRMC1 antibody (20-100 aa) (STJ190957) | Login | Anti-PGRMC1 antibody (20-100 aa) (STJ190957) | ||||||||||||||||
|